Skip to content
NYT Science1 min read

Eli Lilly Will Buy a Narcolepsy Drug Developer...

Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
Read original on nytimes.com
0
0

Comment

Sign in to join the discussion.

Loading comments…

Related

Get the 10 best reads every Sunday

Curated by AI, voted by readers. Free forever.

Liked this? Start your own feed.

0
0